Recent Advances of Cell Membrane Coated Nanoparticles in Treating Cardiovascular Disorders

Cardiovascular diseases (CVDs) are the leading cause of death worldwide, causing approximately 17.9 million deaths annually, an estimated 31% of all deaths, according to the WHO. CVDs are essentially rooted in atherosclerosis and are clinically classified into coronary heart disease, stroke and peri...

Full description

Saved in:
Bibliographic Details
Published inMolecules (Basel, Switzerland) Vol. 26; no. 11; p. 3428
Main Authors Zhu, Chaojie, Ma, Junkai, Ji, Zhiheng, Shen, Jie, Wang, Qiwen
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 05.06.2021
MDPI
Subjects
Anticoagulants
Atherosclerosis
Biomimetic Materials - chemical synthesis
Biomimetic Materials - chemistry
Biomimetic Materials - therapeutic use
Blood clots
Cardiovascular disease
Cardiovascular Diseases - drug therapy
Cell Membrane - chemistry
cell membrane coated nanoparticle
diagnosis and therapy
Drug Delivery Systems
Embolisms
Heart attacks
Humans
Hypertension
Inflammation
Intermittent claudication
Ischemia
Lipoproteins
Magnetic resonance imaging
Medical imaging
Nanomaterials
Nanoparticles
Neutrophils
Prevention
Proteins
Review
Stroke
Thrombosis
atherosclerosis
cardiovascular disease
thrombosis
cell membrane coated nanoparticle
diagnosis and therapy
Online AccessGet full text
ISSN1420-3049
1420-3049
DOI10.3390/molecules26113428

Cover

Abstract Cardiovascular diseases (CVDs) are the leading cause of death worldwide, causing approximately 17.9 million deaths annually, an estimated 31% of all deaths, according to the WHO. CVDs are essentially rooted in atherosclerosis and are clinically classified into coronary heart disease, stroke and peripheral vascular disorders. Current clinical interventions include early diagnosis, the insertion of stents, and long-term preventive therapy. However, clinical diagnostic and therapeutic tools are subject to a number of limitations including, but not limited to, potential toxicity induced by contrast agents and unexpected bleeding caused by anti-platelet drugs. Nanomedicine has achieved great advancements in biomedical area. Among them, cell membrane coated nanoparticles, denoted as CMCNPs, have acquired enormous expectations due to their biomimetic properties. Such membrane coating technology not only helps avoid immune clearance, but also endows nanoparticles with diverse cellular and functional mimicry. In this review, we will describe the superiorities of CMCNPs in treating cardiovascular diseases and their potentials in optimizing current clinical managements.
AbstractList Cardiovascular diseases (CVDs) are the leading cause of death worldwide, causing approximately 17.9 million deaths annually, an estimated 31% of all deaths, according to the WHO. CVDs are essentially rooted in atherosclerosis and are clinically classified into coronary heart disease, stroke and peripheral vascular disorders. Current clinical interventions include early diagnosis, the insertion of stents, and long-term preventive therapy. However, clinical diagnostic and therapeutic tools are subject to a number of limitations including, but not limited to, potential toxicity induced by contrast agents and unexpected bleeding caused by anti-platelet drugs. Nanomedicine has achieved great advancements in biomedical area. Among them, cell membrane coated nanoparticles, denoted as CMCNPs, have acquired enormous expectations due to their biomimetic properties. Such membrane coating technology not only helps avoid immune clearance, but also endows nanoparticles with diverse cellular and functional mimicry. In this review, we will describe the superiorities of CMCNPs in treating cardiovascular diseases and their potentials in optimizing current clinical managements.
Cardiovascular diseases (CVDs) are the leading cause of death worldwide, causing approximately 17.9 million deaths annually, an estimated 31% of all deaths, according to the WHO. CVDs are essentially rooted in atherosclerosis and are clinically classified into coronary heart disease, stroke and peripheral vascular disorders. Current clinical interventions include early diagnosis, the insertion of stents, and long-term preventive therapy. However, clinical diagnostic and therapeutic tools are subject to a number of limitations including, but not limited to, potential toxicity induced by contrast agents and unexpected bleeding caused by anti-platelet drugs. Nanomedicine has achieved great advancements in biomedical area. Among them, cell membrane coated nanoparticles, denoted as CMCNPs, have acquired enormous expectations due to their biomimetic properties. Such membrane coating technology not only helps avoid immune clearance, but also endows nanoparticles with diverse cellular and functional mimicry. In this review, we will describe the superiorities of CMCNPs in treating cardiovascular diseases and their potentials in optimizing current clinical managements.Cardiovascular diseases (CVDs) are the leading cause of death worldwide, causing approximately 17.9 million deaths annually, an estimated 31% of all deaths, according to the WHO. CVDs are essentially rooted in atherosclerosis and are clinically classified into coronary heart disease, stroke and peripheral vascular disorders. Current clinical interventions include early diagnosis, the insertion of stents, and long-term preventive therapy. However, clinical diagnostic and therapeutic tools are subject to a number of limitations including, but not limited to, potential toxicity induced by contrast agents and unexpected bleeding caused by anti-platelet drugs. Nanomedicine has achieved great advancements in biomedical area. Among them, cell membrane coated nanoparticles, denoted as CMCNPs, have acquired enormous expectations due to their biomimetic properties. Such membrane coating technology not only helps avoid immune clearance, but also endows nanoparticles with diverse cellular and functional mimicry. In this review, we will describe the superiorities of CMCNPs in treating cardiovascular diseases and their potentials in optimizing current clinical managements.
Author Wang, Qiwen
Zhu, Chaojie
Ma, Junkai
Ji, Zhiheng
Shen, Jie
AuthorAffiliation 2 Chu Kochen Honors College, Zhejiang University, Hangzhou 310058, China; 3180101531@zju.edu.cn (J.M.); 3180103158@zju.edu.cn (Z.J.)
1 Department of Cardiology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China; 3180101530@zju.edu.cn
3 Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China
4 Department of Pharmacy, School of Medicine, Zhejiang University City College, Hangzhou 310015, China
AuthorAffiliation_xml – name: 1 Department of Cardiology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China; 3180101530@zju.edu.cn
– name: 2 Chu Kochen Honors College, Zhejiang University, Hangzhou 310058, China; 3180101531@zju.edu.cn (J.M.); 3180103158@zju.edu.cn (Z.J.)
– name: 3 Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China
– name: 4 Department of Pharmacy, School of Medicine, Zhejiang University City College, Hangzhou 310015, China
Author_xml – sequence: 1
  givenname: Chaojie
  orcidid: 0000-0002-9375-6725
  surname: Zhu
  fullname: Zhu, Chaojie
– sequence: 2
  givenname: Junkai
  surname: Ma
  fullname: Ma, Junkai
– sequence: 3
  givenname: Zhiheng
  surname: Ji
  fullname: Ji, Zhiheng
– sequence: 4
  givenname: Jie
  surname: Shen
  fullname: Shen, Jie
– sequence: 5
  givenname: Qiwen
  orcidid: 0000-0002-4255-3960
  surname: Wang
  fullname: Wang, Qiwen
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34198794$$D View this record in MEDLINE/PubMed
BookMark eNp1kktv1DAUhS1URNuBH8AGRWLDZsDPJN4gVSmPSgUkVDZsrBv7ZvAoiQc7GYl_j8NMUVvEypZ97nePz_U5ORnDiIQ8Z_S1EJq-GUKPdu4x8ZIxIXn9iJwxyelaUKlP7uxPyXlKW0o5k0w9IadCMl1XWp6R71_R4jgVF24Po8VUhK5osO-LTzi0EUYsmgATuuIzjGEHcfI29yv8WNxEhMmPm6KB6HzYQ8pWIBaXPoXoMKan5HEHfcJnx3VFvr1_d9N8XF9_-XDVXFyvrdRiWndagKIoFVJsteJlbSvVlrqsW9F1rLIdUmCWVjVI6YCVZcVVpUpRo3AgUKzI1YHrAmzNLvoB4i8TwJs_ByFuzNG3yURZOiWdRSVrBK2hRHSUS9WJslKZ9fbA2s3tgG6JJkJ_D3r_ZvQ_zCbsTc0p43oBvDoCYvg5Y5rM4JPNgeYow5wMz33zDGR--oq8fCDdhjmOOaqsElqrStBF9eKuo79WbkeYBdVBYGNIKWJnrJ_yZMJi0PeGUbN8FvPPZ8mV7EHlLfz_Nb8BRwzFVg
CitedBy_id crossref_primary_10_1016_j_smaim_2023_04_002
crossref_primary_10_1002_mabi_202200537
crossref_primary_10_1016_j_matt_2023_01_012
crossref_primary_10_1016_j_bbcan_2022_188703
crossref_primary_10_3390_molecules27041310
crossref_primary_10_3390_biomimetics10030141
crossref_primary_10_3390_pharmaceutics15071953
crossref_primary_10_1002_btm2_70006
crossref_primary_10_1016_j_jconrel_2022_04_046
crossref_primary_10_3390_nano14211757
crossref_primary_10_3390_ijms24065205
crossref_primary_10_1002_sstr_202300004
crossref_primary_10_1680_jbibn_23_00042
crossref_primary_10_1007_s12668_025_01884_9
crossref_primary_10_1186_s12951_023_02004_z
crossref_primary_10_3390_molecules27217492
crossref_primary_10_1007_s12274_022_5002_2
crossref_primary_10_1016_j_bioelechem_2025_108972
crossref_primary_10_1093_cvr_cvaf039
crossref_primary_10_3390_ijms24010787
crossref_primary_10_1002_btm2_10441
crossref_primary_10_3390_molecules29112415
crossref_primary_10_1111_fcp_12915
crossref_primary_10_1016_j_bioadv_2022_213232
crossref_primary_10_3389_fbioe_2024_1349077
crossref_primary_10_3390_nano11112790
crossref_primary_10_3389_fonc_2022_1034842
crossref_primary_10_1007_s13346_024_01763_y
crossref_primary_10_1016_j_lfs_2024_123199
crossref_primary_10_1016_j_medidd_2024_100189
crossref_primary_10_1016_j_mtbio_2023_100633
crossref_primary_10_3390_molecules26165103
Cites_doi 10.1016/j.nantod.2015.06.006
10.1161/CIRCULATIONAHA.107.187998
10.1159/000154811
10.1039/D0BM00029A
10.1002/smll.202006484
10.1007/s12325-011-0026-0
10.1073/pnas.1714267114
10.1021/acsnano.6b07842
10.1016/j.jconrel.2020.08.030
10.1161/HYPERTENSIONAHA.119.14240
10.1016/S0140-6736(07)60716-8
10.1002/advs.201900605
10.18632/oncotarget.7376
10.1186/s12951-018-0392-8
10.3390/ijms20102474
10.1021/acs.biochem.0c00343
10.1002/anie.200902672
10.1182/blood-2007-10-120543
10.2217/nnm.15.26
10.1039/D0BM02125C
10.1038/s41569-018-0098-5
10.1161/JAHA.116.004260
10.1111/bph.13828
10.1126/sciadv.aay9035
10.1002/advs.201900172
10.1038/nri3399
10.1038/bonekey.2013.34
10.1021/acsnano.8b01772
10.1002/smll.201902011
10.1021/acsnano.0c05792
10.1039/D1NR00881A
10.1016/S0140-6736(15)00551-6
10.1038/42408
10.1088/1361-6528/aaa7c7
10.1038/s41467-020-16439-7
10.1136/openhrt-2015-000358
10.1161/01.ATV.0000222152.83069.3f
10.1007/s11051-013-1962-1
10.1002/cbic.201500344
10.1177/2040622319884819
10.1002/adma.201706245
10.1021/acsami.0c13169
10.1038/s41573-020-0090-8
10.5551/jat.RV17022
10.1016/S0167-5273(15)31026-3
10.2217/nnm-2020-0404
10.2217/17435889.2.4.533
10.1002/sstr.202000018
10.3390/nano10040787
10.1038/s41569-019-0326-7
10.1038/nrd2957
10.1016/j.jconrel.2019.01.027
10.1038/nrcardio.2013.165
10.1038/nrdp.2015.6
10.1016/j.nantod.2011.04.001
10.1038/nature06797
10.1021/acsnano.6b03148
10.1002/adma.201606209
10.1016/j.jacc.2005.09.068
10.1161/CIRCULATIONAHA.109.891804
10.1002/btm2.10197
10.1177/0883911518819107
10.1039/C7CS00877E
10.1038/nature15373
10.1016/j.biomaterials.2020.119942
10.1038/nnano.2017.54
10.1017/S0266462300006061
10.1021/acsami.9b04735
10.1371/journal.pone.0191817
10.1016/j.biomaterials.2018.05.015
10.1021/acsnano.9b08216
10.1161/01.ATV.21.1.115
10.3390/jcm9072064
10.1039/C9NR01292C
10.2217/nnm-2015-0007
10.1021/acsabm.0c01014
10.1038/nrcardio.2013.73
10.7150/thno.20118
10.1021/nl500618u
10.1016/S0735-1097(02)02834-6
10.1161/CIRCULATIONAHA.105.595918
10.1038/s41569-018-0110-0
10.1002/advs.202004128
10.1021/acsnano.8b06572
10.1073/pnas.1106634108
10.1161/01.CIR.0000086897.15588.4B
10.1177/2048872612441582
10.1038/s41565-019-0619-3
10.7150/thno.47841
10.1016/j.apsb.2019.01.011
10.1039/D0BM00474J
10.1021/acs.accounts.9b00079
10.3390/jcdd6020019
10.1161/CIRCRESAHA.114.302721
10.1016/S0140-6736(16)31012-1
10.1126/science.288.5473.2051
10.1039/C9MH01068H
10.4239/wjd.v6.i13.1246
10.1080/14779072.2018.1435274
10.1021/acs.nanolett.9b01282
10.1378/chest.11-2302
10.1016/j.biomaterials.2018.08.018
10.1038/s41573-019-0054-z
10.1002/pds.1916
10.1016/j.nano.2018.08.002
10.1530/VB-19-0011
10.2217/nnm-2019-0388
10.1021/acsami.8b11645
10.1007/s00604-020-4130-1
10.1161/ATVBAHA.120.313584
10.1155/2012/245037
10.1021/acsnano.0c07973
10.1002/anie.201906280
10.1097/SHK.0000000000000044
10.1021/acsnano.9b08587
10.1038/s41569-018-0119-4
10.1038/s41565-020-0669-6
10.1093/cvr/cvz156
10.1039/D0BM01164A
10.4103/2229-5151.109429
10.1080/10717544.2020.1754525
10.1126/science.1256478
10.1038/s41565-018-0254-4
10.1038/nnano.2013.254
10.1038/nnano.2013.54
10.1126/sciadv.aaw6870
10.1038/nri3520
10.3389/fonc.2019.01560
10.1179/2295333714Y.0000000069
10.1038/s41598-019-51029-8
10.1016/j.blre.2009.07.002
ContentType Journal Article
Copyright 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2021 by the authors. 2021
Copyright_xml – notice: 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2021 by the authors. 2021
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.3390/molecules26113428
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection (ProQuest)
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
Publicly Available Content Database

MEDLINE
MEDLINE - Academic
CrossRef
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
EISSN 1420-3049
ExternalDocumentID oai_doaj_org_article_b3f46d54dce548ea99a6eed0245f3675
PMC8201295
34198794
10_3390_molecules26113428
Genre Journal Article
Review
GrantInformation_xml – fundername: National Natural Science Foundation of China
  grantid: 81800442
GroupedDBID ---
0R~
123
2WC
53G
5VS
7X7
88E
8FE
8FG
8FH
8FI
8FJ
A8Z
AADQD
AAFWJ
AAHBH
AAYXX
ABDBF
ABUWG
ACGFO
ACIWK
ACPRK
ACUHS
AEGXH
AENEX
AFKRA
AFPKN
AFRAH
AFZYC
AIAGR
ALIPV
ALMA_UNASSIGNED_HOLDINGS
BENPR
BPHCQ
BVXVI
CCPQU
CITATION
CS3
D1I
DIK
DU5
E3Z
EBD
EMOBN
ESX
FYUFA
GROUPED_DOAJ
GX1
HH5
HMCUK
HYE
HZ~
I09
IAO
IHR
ITC
KQ8
LK8
M1P
MODMG
O-U
O9-
OK1
P2P
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RPM
SV3
TR2
TUS
UKHRP
~8M
3V.
ABJCF
BBNVY
BHPHI
CGR
CUY
CVF
ECM
EIF
HCIFZ
KB.
M7P
M~E
NPM
PDBOC
7XB
8FK
AZQEC
DWQXO
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c493t-f93a50e45e0eb95268c75b6968b3ff17cfe0a1c078a44da16672575638e3da3e3
IEDL.DBID DOA
ISSN 1420-3049
IngestDate Wed Aug 27 01:30:00 EDT 2025
Thu Aug 21 14:12:09 EDT 2025
Fri Jul 11 15:41:52 EDT 2025
Fri Jul 25 09:52:28 EDT 2025
Wed Feb 19 02:06:31 EST 2025
Thu Apr 24 23:08:45 EDT 2025
Tue Jul 01 03:11:46 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 11
Keywords atherosclerosis
cardiovascular disease
thrombosis
cell membrane coated nanoparticle
diagnosis and therapy
Language English
License https://creativecommons.org/licenses/by/4.0
Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c493t-f93a50e45e0eb95268c75b6968b3ff17cfe0a1c078a44da16672575638e3da3e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
These authors contribute equally.
ORCID 0000-0002-9375-6725
0000-0002-4255-3960
OpenAccessLink https://doaj.org/article/b3f46d54dce548ea99a6eed0245f3675
PMID 34198794
PQID 2539957309
PQPubID 2032355
ParticipantIDs doaj_primary_oai_doaj_org_article_b3f46d54dce548ea99a6eed0245f3675
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8201295
proquest_miscellaneous_2548415449
proquest_journals_2539957309
pubmed_primary_34198794
crossref_citationtrail_10_3390_molecules26113428
crossref_primary_10_3390_molecules26113428
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20210605
PublicationDateYYYYMMDD 2021-06-05
PublicationDate_xml – month: 6
  year: 2021
  text: 20210605
  day: 5
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Basel
PublicationTitle Molecules (Basel, Switzerland)
PublicationTitleAlternate Molecules
PublicationYear 2021
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References Liu (ref_63) 2020; 27
Zhang (ref_73) 2018; 174
Wang (ref_83) 2020; 1
Zhang (ref_112) 2018; 13
Feng (ref_114) 2021; 15
ref_11
Dai (ref_14) 2012; 2012
ref_99
ref_98
Bloom (ref_41) 1989; 5
Keto (ref_21) 2016; 3
Hu (ref_64) 2020; 187
ref_18
Fang (ref_87) 2014; 14
Wang (ref_74) 2020; 8
Zhang (ref_90) 2019; 58
ref_128
ref_25
Leon (ref_23) 2015; 6
ref_24
Morishige (ref_51) 2010; 122
Braster (ref_81) 2020; 17
ref_20
Wang (ref_1) 2016; 388
Cao (ref_62) 2016; 10
Yan (ref_132) 2019; 6
Asada (ref_36) 2018; 25
Marsh (ref_56) 2007; 2
Wang (ref_109) 2021; 11
Xu (ref_77) 2019; 34
Guthrie (ref_15) 2011; 28
Lyaker (ref_38) 2013; 3
Lee (ref_116) 2006; 114
Gao (ref_108) 2020; 11
Fuchs (ref_22) 2020; 75
Wang (ref_97) 2020; 328
Li (ref_76) 2020; 8
Cheng (ref_130) 2016; 17
ref_75
Michelson (ref_4) 2010; 9
Hu (ref_78) 2015; 526
Zhou (ref_2) 2016; 387
Knop (ref_19) 2010; 49
Xia (ref_82) 2019; 9
Bentzon (ref_27) 2014; 114
Bansilal (ref_10) 2015; 201
Liu (ref_48) 2013; 15
Stephan (ref_131) 2011; 6
ref_80
Chen (ref_40) 2018; 175
Simons (ref_60) 1997; 387
Falk (ref_29) 2006; 47
Meyer (ref_72) 2020; 6
Jin (ref_120) 2020; 9
Chu (ref_86) 2018; 30
Su (ref_70) 2020; 7
Adhyaru (ref_6) 2018; 15
Wang (ref_88) 2021; 9
Sherwood (ref_68) 2019; 11
Qiao (ref_50) 2017; 11
Meng (ref_67) 2018; 29
Hu (ref_92) 2013; 8
Cappelletto (ref_7) 2019; 1
Cheng (ref_129) 2020; 15
Huang (ref_123) 2021; 16
Byrne (ref_8) 2014; 11
Zou (ref_59) 2020; 15
Peng (ref_65) 2020; 3
Mohebbi (ref_12) 2010; 19
Wolberg (ref_45) 2015; 1
Wang (ref_89) 2020; 12
Palekar (ref_49) 2015; 10
Badimon (ref_35) 2012; 1
Lansberg (ref_5) 2012; 141
Thamphiwatana (ref_84) 2017; 114
Xue (ref_111) 2017; 12
Cai (ref_66) 2019; 9
Dehaini (ref_126) 2017; 29
Armitage (ref_53) 2007; 370
Song (ref_122) 2019; 15
Shah (ref_32) 2003; 41
Lim (ref_106) 2016; 7
Oldenborg (ref_91) 2000; 288
Zhai (ref_61) 2017; 7
Pernow (ref_79) 2019; 115
Peng (ref_85) 2020; 2020
Zhao (ref_28) 2019; 16
Li (ref_124) 2020; 14
Sperandio (ref_39) 2020; 19
Ai (ref_133) 2021; 60
Shao (ref_95) 2018; 12
Sreeramkumar (ref_101) 2014; 346
Tang (ref_103) 2019; 19
Shang (ref_71) 2019; 11
Ma (ref_125) 2019; 15
McKavanagh (ref_9) 2018; 16
Kim (ref_118) 2020; 243
ref_115
Sparrow (ref_52) 2001; 21
Verna (ref_30) 2006; 26
Flores (ref_55) 2020; 15
ref_110
ref_113
(ref_26) 2014; 69
Schofield (ref_102) 2013; 40
ref_37
Bagheri (ref_46) 2016; 11
Zhao (ref_107) 2018; 10
Mitchell (ref_16) 2021; 20
Gustafson (ref_17) 2015; 10
Oza (ref_13) 2017; 96
Heemskerk (ref_96) 2019; 16
ref_104
ref_105
Hu (ref_58) 2011; 108
Moore (ref_31) 2013; 13
Crowther (ref_44) 2008; 111
Hu (ref_93) 2013; 8
Strobel (ref_121) 2008; 35
Mackman (ref_34) 2008; 451
ref_43
Patra (ref_47) 2018; 16
Wang (ref_94) 2019; 6
Bose (ref_117) 2018; 185
Oroojalian (ref_119) 2021; 17
Han (ref_127) 2019; 5
Kim (ref_54) 2020; 14
Liang (ref_69) 2019; 296
Makaryus (ref_3) 2013; 10
Spicer (ref_57) 2018; 47
Esmon (ref_33) 2009; 23
Nelson (ref_42) 2019; 10
Kolaczkowska (ref_100) 2013; 13
References_xml – volume: 10
  start-page: 487
  year: 2015
  ident: ref_17
  article-title: Nanoparticle uptake: The phagocyte problem
  publication-title: Nano Today
  doi: 10.1016/j.nantod.2015.06.006
– ident: ref_37
  doi: 10.1161/CIRCULATIONAHA.107.187998
– volume: 35
  start-page: 346
  year: 2008
  ident: ref_121
  article-title: Hemolytic transfusion reactions
  publication-title: Transfus. Med. Hemother.
  doi: 10.1159/000154811
– volume: 8
  start-page: 1802
  year: 2020
  ident: ref_76
  article-title: Red blood cell membrane-coated upconversion nanoparticles for pretargeted multimodality imaging of triple-negative breast cancer
  publication-title: Biomater. Sci.
  doi: 10.1039/D0BM00029A
– volume: 17
  start-page: 2006484
  year: 2021
  ident: ref_119
  article-title: Immune cell membrane-coated biomimetic nanoparticles for targeted cancer therapy
  publication-title: Small
  doi: 10.1002/smll.202006484
– volume: 28
  start-page: 473
  year: 2011
  ident: ref_15
  article-title: Review and management of side effects associated with antiplatelet therapy for prevention of recurrent cerebrovascular events
  publication-title: Adv. Ther.
  doi: 10.1007/s12325-011-0026-0
– volume: 114
  start-page: 11488
  year: 2017
  ident: ref_84
  article-title: Macrophage-like nanoparticles concurrently absorbing endotoxins and proinflammatory cytokines for sepsis management
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.1714267114
– volume: 11
  start-page: 1816
  year: 2017
  ident: ref_50
  article-title: Molecular imaging of vulnerable atherosclerotic plaques in vivo with osteopontin-specific upconversion nanoprobes
  publication-title: ACS Nano
  doi: 10.1021/acsnano.6b07842
– volume: 328
  start-page: 78
  year: 2020
  ident: ref_97
  article-title: Platelet membrane-functionalized nanoparticles with improved targeting ability and lower hemorrhagic risk for thrombolysis therapy
  publication-title: J. Control. Release
  doi: 10.1016/j.jconrel.2020.08.030
– volume: 96
  start-page: 436
  year: 2017
  ident: ref_13
  article-title: Recurrent ischemic stroke: Strategies for prevention
  publication-title: Am. Fam. Physician
– volume: 75
  start-page: 285
  year: 2020
  ident: ref_22
  article-title: High blood pressure and cardiovascular disease
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.119.14240
– volume: 370
  start-page: 1781
  year: 2007
  ident: ref_53
  article-title: The safety of statins in clinical practice
  publication-title: Lancet
  doi: 10.1016/S0140-6736(07)60716-8
– volume: 6
  start-page: 1900605
  year: 2019
  ident: ref_132
  article-title: Engineering cell membrane-based nanotherapeutics to target inflammation
  publication-title: Adv. Sci.
  doi: 10.1002/advs.201900605
– volume: 7
  start-page: 28697
  year: 2016
  ident: ref_106
  article-title: Targeting the CCL2-CCR2 signaling axis in cancer metastasis
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.7376
– volume: 16
  start-page: 71
  year: 2018
  ident: ref_47
  article-title: Nano based drug delivery systems: Recent developments and future prospects
  publication-title: J. Nanobiotechnol.
  doi: 10.1186/s12951-018-0392-8
– ident: ref_105
  doi: 10.3390/ijms20102474
– volume: 60
  start-page: 941
  year: 2021
  ident: ref_133
  article-title: Emerging approaches to functionalizing cell membrane-coated nanoparticles
  publication-title: Biochemistry
  doi: 10.1021/acs.biochem.0c00343
– volume: 49
  start-page: 6288
  year: 2010
  ident: ref_19
  article-title: Poly (Ethylene Glycol) in drug delivery: Pros and cons as well as potential alternatives
  publication-title: Angew. Chem. Int. Ed.
  doi: 10.1002/anie.200902672
– volume: 111
  start-page: 4871
  year: 2008
  ident: ref_44
  article-title: Bleeding risk and the management of bleeding complications in patients undergoing anticoagulant therapy: Focus on new anticoagulant agents
  publication-title: Blood
  doi: 10.1182/blood-2007-10-120543
– volume: 10
  start-page: 1817
  year: 2015
  ident: ref_49
  article-title: Molecular imaging of atherosclerosis with nanoparticle-based fluorinated MRI contrast agents
  publication-title: Nanomedicine
  doi: 10.2217/nnm.15.26
– ident: ref_98
  doi: 10.1039/D0BM02125C
– volume: 15
  start-page: 757
  year: 2018
  ident: ref_6
  article-title: Safety and efficacy of statin therapy
  publication-title: Nat. Rev. Cardiol.
  doi: 10.1038/s41569-018-0098-5
– ident: ref_25
  doi: 10.1161/JAHA.116.004260
– volume: 175
  start-page: 1279
  year: 2018
  ident: ref_40
  article-title: Reactive oxygen species: Key regulators in vascular health and diseases: ROS in vascular diseases
  publication-title: Br. J. Pharmacol.
  doi: 10.1111/bph.13828
– volume: 6
  start-page: eaay9035
  year: 2020
  ident: ref_72
  article-title: Biomimetic anisotropic polymeric nanoparticles coated with red blood cell membranes for enhanced circulation and toxin removal
  publication-title: Sci. Adv.
  doi: 10.1126/sciadv.aay9035
– volume: 6
  start-page: 1900172
  year: 2019
  ident: ref_94
  article-title: Biomimetic nanotherapies: Red blood cell based core–shell structured nanocomplexes for atherosclerosis management
  publication-title: Adv. Sci.
  doi: 10.1002/advs.201900172
– volume: 13
  start-page: 159
  year: 2013
  ident: ref_100
  article-title: Neutrophil recruitment and function in health and inflammation
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/nri3399
– volume: 2020
  start-page: 1
  year: 2020
  ident: ref_85
  article-title: Macrophage-based therapies for atherosclerosis management
  publication-title: J. Immunol. Res.
– ident: ref_115
  doi: 10.1038/bonekey.2013.34
– volume: 12
  start-page: 4877
  year: 2018
  ident: ref_95
  article-title: Erythrocyte membrane modified janus polymeric motors for thrombus therapy
  publication-title: ACS Nano
  doi: 10.1021/acsnano.8b01772
– volume: 15
  start-page: 1902011
  year: 2019
  ident: ref_125
  article-title: Targeted drug delivery to stroke via chemotactic recruitment of nanoparticles coated with membrane of engineered neural stem cells
  publication-title: Small
  doi: 10.1002/smll.201902011
– ident: ref_128
  doi: 10.1021/acsnano.0c05792
– ident: ref_75
  doi: 10.1039/D1NR00881A
– volume: 387
  start-page: 251
  year: 2016
  ident: ref_2
  article-title: Cause-specific mortality for 240 causes in china during 1990–2013: A systematic subnational analysis for the global burden of disease study 2013
  publication-title: Lancet
  doi: 10.1016/S0140-6736(15)00551-6
– volume: 387
  start-page: 569
  year: 1997
  ident: ref_60
  article-title: Functional rafts in cell membranes
  publication-title: Nature
  doi: 10.1038/42408
– volume: 29
  start-page: 134004
  year: 2018
  ident: ref_67
  article-title: Macrophage membrane-coated iron oxide nanoparticles for enhanced photothermal tumor therapy
  publication-title: Nanotechnology
  doi: 10.1088/1361-6528/aaa7c7
– volume: 11
  start-page: 2622
  year: 2020
  ident: ref_108
  article-title: Treatment of atherosclerosis by macrophage-biomimetic nanoparticles via targeted pharmacotherapy and sequestration of proinflammatory cytokines
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-020-16439-7
– volume: 3
  start-page: e000358
  year: 2016
  ident: ref_21
  article-title: Cardiovascular disease risk factors in relation to smoking behaviour and history: A population-based cohort study
  publication-title: Open Heart
  doi: 10.1136/openhrt-2015-000358
– volume: 26
  start-page: 1344
  year: 2006
  ident: ref_30
  article-title: In vivo low-density lipoprotein exposure induces intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 correlated with activator protein-1 expression
  publication-title: ATVB
  doi: 10.1161/01.ATV.0000222152.83069.3f
– volume: 15
  start-page: 1962
  year: 2013
  ident: ref_48
  article-title: Advanced stent coating for drug delivery and in vivo biocompatibility
  publication-title: J. Nanopart. Res.
  doi: 10.1007/s11051-013-1962-1
– volume: 17
  start-page: 11
  year: 2016
  ident: ref_130
  article-title: Metabolic remodeling of cell-surface sialic acids: Principles, applications, and recent advances
  publication-title: ChemBioChem
  doi: 10.1002/cbic.201500344
– volume: 10
  start-page: 204062231988481
  year: 2019
  ident: ref_42
  article-title: Current approach to the diagnosis of atherosclerotic coronary artery disease: More questions than answers
  publication-title: Ther. Adv. Chronic Dis.
  doi: 10.1177/2040622319884819
– volume: 30
  start-page: 1706245
  year: 2018
  ident: ref_86
  article-title: Neutrophil-based drug delivery systems
  publication-title: Adv. Mater.
  doi: 10.1002/adma.201706245
– volume: 12
  start-page: 41138
  year: 2020
  ident: ref_89
  article-title: Bacterial vesicle-cancer cell hybrid membrane-coated nanoparticles for tumor specific immune activation and photothermal therapy
  publication-title: ACS Appl. Mater. Interfaces
  doi: 10.1021/acsami.0c13169
– volume: 20
  start-page: 101
  year: 2021
  ident: ref_16
  article-title: Engineering precision nanoparticles for drug delivery
  publication-title: Nat. Rev. Drug Discov.
  doi: 10.1038/s41573-020-0090-8
– volume: 25
  start-page: 653
  year: 2018
  ident: ref_36
  article-title: Thrombus formation and propagation in the onset of cardiovascular events
  publication-title: J Atheroscler. Thromb.
  doi: 10.5551/jat.RV17022
– volume: 201
  start-page: S1
  year: 2015
  ident: ref_10
  article-title: Global burden of CVD: Focus on secondary prevention of cardiovascular disease
  publication-title: Int. J. Cardiol.
  doi: 10.1016/S0167-5273(15)31026-3
– volume: 16
  start-page: 465
  year: 2021
  ident: ref_123
  article-title: Erythrocyte membrane coated nanoparticle-based control releasing hydrogen sulfide system protects ischemic myocardium
  publication-title: Nanomedicine
  doi: 10.2217/nnm-2020-0404
– volume: 2
  start-page: 533
  year: 2007
  ident: ref_56
  article-title: Fibrin-targeted perfluorocarbon nanoparticles for targeted thrombolysis
  publication-title: Nanomedicine
  doi: 10.2217/17435889.2.4.533
– volume: 1
  start-page: 2000018
  year: 2020
  ident: ref_83
  article-title: Drug targeting via platelet membrane—Coated nanoparticles
  publication-title: Small Struct.
  doi: 10.1002/sstr.202000018
– ident: ref_18
  doi: 10.3390/nano10040787
– volume: 17
  start-page: 327
  year: 2020
  ident: ref_81
  article-title: Neutrophils as regulators of cardiovascular inflammation
  publication-title: Nat. Rev. Cardiol.
  doi: 10.1038/s41569-019-0326-7
– volume: 9
  start-page: 154
  year: 2010
  ident: ref_4
  article-title: Antiplatelet therapies for the treatment of cardiovascular disease
  publication-title: Nat. Rev. Drug Discov.
  doi: 10.1038/nrd2957
– volume: 296
  start-page: 150
  year: 2019
  ident: ref_69
  article-title: Photothermal cancer immunotherapy by erythrocyte membrane-coated black phosphorus formulation
  publication-title: J. Control. Release
  doi: 10.1016/j.jconrel.2019.01.027
– volume: 11
  start-page: 13
  year: 2014
  ident: ref_8
  article-title: Drug-coated balloon therapy in coronary and peripheral artery disease
  publication-title: Nat. Rev. Cardiol.
  doi: 10.1038/nrcardio.2013.165
– volume: 1
  start-page: 15006
  year: 2015
  ident: ref_45
  article-title: Venous thrombosis
  publication-title: Nat. Rev. Dis. Primers
  doi: 10.1038/nrdp.2015.6
– volume: 6
  start-page: 309
  year: 2011
  ident: ref_131
  article-title: Enhancing cell therapies from the outside in: Cell surface engineering using synthetic nanomaterials
  publication-title: Nano Today
  doi: 10.1016/j.nantod.2011.04.001
– volume: 451
  start-page: 914
  year: 2008
  ident: ref_34
  article-title: Triggers, targets and treatments for thrombosis
  publication-title: Nature
  doi: 10.1038/nature06797
– volume: 10
  start-page: 7738
  year: 2016
  ident: ref_62
  article-title: Liposomes coated with isolated macrophage membrane can target lung metastasis of breast cancer
  publication-title: ACS Nano
  doi: 10.1021/acsnano.6b03148
– volume: 29
  start-page: 1606209
  year: 2017
  ident: ref_126
  article-title: Erythrocyte-platelet hybrid membrane coating for enhanced nanoparticle functionalization
  publication-title: Adv. Mater.
  doi: 10.1002/adma.201606209
– volume: 47
  start-page: C7
  year: 2006
  ident: ref_29
  article-title: Pathogenesis of atherosclerosis
  publication-title: J. Am. Coll. Cardiol.
  doi: 10.1016/j.jacc.2005.09.068
– volume: 122
  start-page: 1707
  year: 2010
  ident: ref_51
  article-title: High-resolution magnetic resonance imaging enhanced with superparamagnetic nanoparticles measures macrophage burden in atherosclerosis
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.109.891804
– ident: ref_110
  doi: 10.1002/btm2.10197
– volume: 34
  start-page: 58
  year: 2019
  ident: ref_77
  article-title: Cancer cell membrane—Coated nanocarriers for homologous target inhibiting the growth of hepatocellular carcinoma
  publication-title: J. Bioact. Compat. Polym.
  doi: 10.1177/0883911518819107
– volume: 47
  start-page: 3574
  year: 2018
  ident: ref_57
  article-title: Peptide and protein nanoparticle conjugates: Versatile platforms for biomedical applications
  publication-title: Chem. Soc. Rev.
  doi: 10.1039/C7CS00877E
– volume: 526
  start-page: 118
  year: 2015
  ident: ref_78
  article-title: Nanoparticle biointerfacing by platelet membrane cloaking
  publication-title: Nature
  doi: 10.1038/nature15373
– volume: 243
  start-page: 119942
  year: 2020
  ident: ref_118
  article-title: Mesenchymal stem cell-derived magnetic extracellular nanovesicles for targeting and treatment of ischemic stroke
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2020.119942
– volume: 12
  start-page: 692
  year: 2017
  ident: ref_111
  article-title: Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence
  publication-title: Nat. Nanotechnol.
  doi: 10.1038/nnano.2017.54
– volume: 5
  start-page: 154
  year: 1989
  ident: ref_41
  article-title: The Swedish council on technology assessment in health care
  publication-title: Int. J. Technol. Assess. Health Care
  doi: 10.1017/S0266462300006061
– volume: 11
  start-page: 28254
  year: 2019
  ident: ref_71
  article-title: Platelet-membrane-camouflaged black phosphorus quantum dots enhance anticancer effect mediated by apoptosis and autophagy
  publication-title: ACS Appl. Mater. Interfaces
  doi: 10.1021/acsami.9b04735
– ident: ref_43
  doi: 10.1371/journal.pone.0191817
– volume: 174
  start-page: 54
  year: 2018
  ident: ref_73
  article-title: Efficient co-delivery of neo-epitopes using dispersion-stable layered double hydroxide nanoparticles for enhanced melanoma immunotherapy
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2018.05.015
– volume: 14
  start-page: 6519
  year: 2020
  ident: ref_54
  article-title: Affinity-driven design of cargo-switching nanoparticles to leverage a cholesterol-rich microenvironment for atherosclerosis therapy
  publication-title: ACS Nano
  doi: 10.1021/acsnano.9b08216
– volume: 21
  start-page: 115
  year: 2001
  ident: ref_52
  article-title: Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol lowering
  publication-title: Arterioscler. Thromb. Vasc. Biol.
  doi: 10.1161/01.ATV.21.1.115
– ident: ref_11
  doi: 10.3390/jcm9072064
– volume: 11
  start-page: 6352
  year: 2019
  ident: ref_68
  article-title: Cell-membrane coated iron oxide nanoparticles for isolation and specific identification of drug leads from complex matrices
  publication-title: Nanoscale
  doi: 10.1039/C9NR01292C
– volume: 11
  start-page: 1309
  year: 2016
  ident: ref_46
  article-title: Nanomaterial coatings applied on stent surfaces
  publication-title: Nanomedicine
  doi: 10.2217/nnm-2015-0007
– volume: 3
  start-page: 7849
  year: 2020
  ident: ref_65
  article-title: Biomimetic mesoporous silica nanoparticles for enhanced blood circulation and cancer therapy
  publication-title: ACS Appl. Bio Mater.
  doi: 10.1021/acsabm.0c01014
– volume: 10
  start-page: 397
  year: 2013
  ident: ref_3
  article-title: Oral anticoagulants in the management of venous thromboembolism
  publication-title: Nat. Rev. Cardiol.
  doi: 10.1038/nrcardio.2013.73
– volume: 7
  start-page: 2575
  year: 2017
  ident: ref_61
  article-title: Preparation and application of cell membrane-camouflaged nanoparticles for cancer therapy
  publication-title: Theranostics
  doi: 10.7150/thno.20118
– volume: 14
  start-page: 2181
  year: 2014
  ident: ref_87
  article-title: Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery
  publication-title: Nano Lett.
  doi: 10.1021/nl500618u
– volume: 41
  start-page: 15S
  year: 2003
  ident: ref_32
  article-title: Mechanisms of plaque vulnerability and rupture
  publication-title: J. Am. Coll. Cardiol.
  doi: 10.1016/S0735-1097(02)02834-6
– volume: 114
  start-page: 150
  year: 2006
  ident: ref_116
  article-title: Integrin-linked kinase, a hypoxia-responsive molecule, controls postnatal vasculogenesis by recruitment of endothelial progenitor cells to ischemic tissue
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.105.595918
– volume: 16
  start-page: 166
  year: 2019
  ident: ref_96
  article-title: Platelet biology and functions: New concepts and clinical perspectives
  publication-title: Nat. Rev. Cardiol.
  doi: 10.1038/s41569-018-0110-0
– ident: ref_99
  doi: 10.1002/advs.202004128
– ident: ref_113
  doi: 10.1021/acsnano.8b06572
– volume: 108
  start-page: 10980
  year: 2011
  ident: ref_58
  article-title: Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.1106634108
– ident: ref_80
  doi: 10.1161/01.CIR.0000086897.15588.4B
– volume: 1
  start-page: 60
  year: 2012
  ident: ref_35
  article-title: Atherosclerosis, platelets and thrombosis in acute ischaemic heart disease
  publication-title: Eur. Heart J. Acute Cardiovasc. Care
  doi: 10.1177/2048872612441582
– volume: 15
  start-page: 154
  year: 2020
  ident: ref_55
  article-title: Pro-efferocytic nanoparticles are specifically taken up by lesional macrophages and prevent atherosclerosis
  publication-title: Nat. Nanotechnol.
  doi: 10.1038/s41565-019-0619-3
– volume: 11
  start-page: 164
  year: 2021
  ident: ref_109
  article-title: Macrophage membrane functionalized biomimetic nanoparticles for targeted anti-atherosclerosis applications
  publication-title: Theranostics
  doi: 10.7150/thno.47841
– volume: 9
  start-page: 675
  year: 2019
  ident: ref_82
  article-title: Red blood cell membrane-camouflaged nanoparticles: A novel drug delivery system for antitumor application
  publication-title: Acta Pharm. Sin. B
  doi: 10.1016/j.apsb.2019.01.011
– volume: 8
  start-page: 3370
  year: 2020
  ident: ref_74
  article-title: A versatile ultrafine and super-absorptive H+ -modified montmorillonite: Application for metabolic syndrome intervention and gastric mucosal protection
  publication-title: Biomater. Sci.
  doi: 10.1039/D0BM00474J
– ident: ref_20
  doi: 10.1021/acs.accounts.9b00079
– ident: ref_24
  doi: 10.3390/jcdd6020019
– volume: 114
  start-page: 1852
  year: 2014
  ident: ref_27
  article-title: Mechanisms of plaque formation and rupture
  publication-title: Circ. Res.
  doi: 10.1161/CIRCRESAHA.114.302721
– volume: 388
  start-page: 1459
  year: 2016
  ident: ref_1
  article-title: Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: A systematic analysis for the global burden of disease study 2015
  publication-title: Lancet
  doi: 10.1016/S0140-6736(16)31012-1
– volume: 288
  start-page: 2051
  year: 2000
  ident: ref_91
  article-title: Role of CD47 as a marker of self on red blood cells
  publication-title: Science
  doi: 10.1126/science.288.5473.2051
– volume: 7
  start-page: 574
  year: 2020
  ident: ref_70
  article-title: A neutrophil membrane-functionalized black phosphorus riding inflammatory signal for positive feedback and multimode cancer therapy
  publication-title: Mater. Horiz.
  doi: 10.1039/C9MH01068H
– volume: 6
  start-page: 1246
  year: 2015
  ident: ref_23
  article-title: Diabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future research
  publication-title: WJD
  doi: 10.4239/wjd.v6.i13.1246
– volume: 16
  start-page: 219
  year: 2018
  ident: ref_9
  article-title: The evolution of coronary stents
  publication-title: Expert Rev. Cardiovasc. Ther.
  doi: 10.1080/14779072.2018.1435274
– volume: 19
  start-page: 4470
  year: 2019
  ident: ref_103
  article-title: Recognition, intervention, and monitoring of neutrophils in acute ischemic stroke
  publication-title: Nano Lett.
  doi: 10.1021/acs.nanolett.9b01282
– volume: 141
  start-page: e601S
  year: 2012
  ident: ref_5
  article-title: Antithrombotic and thrombolytic therapy for ischemic stroke: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
  publication-title: Chest
  doi: 10.1378/chest.11-2302
– volume: 185
  start-page: 360
  year: 2018
  ident: ref_117
  article-title: Bioengineered stem cell membrane functionalized nanocarriers for therapeutic targeting of severe hindlimb ischemia
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2018.08.018
– volume: 19
  start-page: 253
  year: 2020
  ident: ref_39
  article-title: Neutrophils as emerging therapeutic targets
  publication-title: Nat. Rev. Drug Discov.
  doi: 10.1038/s41573-019-0054-z
– volume: 19
  start-page: 889
  year: 2010
  ident: ref_12
  article-title: Adverse drug reactions induced by cardiovascular drugs in cardiovascular care unit patients: Adverse drug reactions induced by cardiovascular drugs
  publication-title: Pharmacoepidemiol. Drug Saf.
  doi: 10.1002/pds.1916
– volume: 15
  start-page: 13
  year: 2019
  ident: ref_122
  article-title: Platelet membrane-coated nanoparticle-mediated targeting delivery of rapamycin blocks atherosclerotic plaque development and stabilizes plaque in apolipoprotein e-deficient (ApoE−/−) mice
  publication-title: Nanomed. Nanotechnol. Biol. Med.
  doi: 10.1016/j.nano.2018.08.002
– volume: 1
  start-page: H47
  year: 2019
  ident: ref_7
  article-title: Cardiac revascularization: State of the art and perspectives
  publication-title: Vasc. Biol.
  doi: 10.1530/VB-19-0011
– volume: 15
  start-page: 625
  year: 2020
  ident: ref_59
  article-title: Cell membrane-coated nanoparticles: Research advances
  publication-title: Nanomedicine
  doi: 10.2217/nnm-2019-0388
– volume: 10
  start-page: 31124
  year: 2018
  ident: ref_107
  article-title: C–C Chemokine Ligand 2 (CCL2) recruits macrophage-membrane-camouflaged hollow bismuth selenide nanoparticles to facilitate photothermal sensitivity and inhibit lung metastasis of breast cancer
  publication-title: ACS Appl. Mater. Interfaces
  doi: 10.1021/acsami.8b11645
– volume: 187
  start-page: 175
  year: 2020
  ident: ref_64
  article-title: Cell membrane-coated gold nanoparticles for apoptosis imaging in living cells based on fluorescent determination
  publication-title: Microchim. Acta
  doi: 10.1007/s00604-020-4130-1
– ident: ref_104
  doi: 10.1161/ATVBAHA.120.313584
– volume: 2012
  start-page: 245037
  year: 2012
  ident: ref_14
  article-title: Clinical use of aspirin in treatment and prevention of cardiovascular disease
  publication-title: Thrombosis
  doi: 10.1155/2012/245037
– volume: 15
  start-page: 2263
  year: 2021
  ident: ref_114
  article-title: Neutrophil-like cell-membrane-coated nanozyme therapy for ischemic brain damage and long-term neurological functional recovery
  publication-title: ACS Nano
  doi: 10.1021/acsnano.0c07973
– volume: 58
  start-page: 11404
  year: 2019
  ident: ref_90
  article-title: Inhibition of pathogen adhesion by bacterial outer membrane-coated nanoparticles
  publication-title: Angew. Chem. Int. Ed.
  doi: 10.1002/anie.201906280
– volume: 40
  start-page: 463
  year: 2013
  ident: ref_102
  article-title: Neutrophils—A key component of ischemia-reperfusion injury
  publication-title: Shock
  doi: 10.1097/SHK.0000000000000044
– volume: 14
  start-page: 2024
  year: 2020
  ident: ref_124
  article-title: Platelet membrane biomimetic magnetic nanocarriers for targeted delivery and in situ generation of nitric oxide in early ischemic stroke
  publication-title: ACS Nano
  doi: 10.1021/acsnano.9b08587
– volume: 16
  start-page: 203
  year: 2019
  ident: ref_28
  article-title: Epidemiology of cardiovascular disease in China: Current features and implications
  publication-title: Nat. Rev. Cardiol.
  doi: 10.1038/s41569-018-0119-4
– volume: 15
  start-page: 313
  year: 2020
  ident: ref_129
  article-title: Selective organ targeting (SORT) nanoparticles for tissue-specific MRNA delivery and CRISPR–Cas gene editing
  publication-title: Nat. Nanotechnol.
  doi: 10.1038/s41565-020-0669-6
– volume: 115
  start-page: 1596
  year: 2019
  ident: ref_79
  article-title: Red blood cell dysfunction: A new player in cardiovascular disease
  publication-title: Cardiovasc. Res.
  doi: 10.1093/cvr/cvz156
– volume: 9
  start-page: 1088
  year: 2021
  ident: ref_88
  article-title: Recent advances in mesenchymal stem cell membrane-coated nanoparticles for enhanced drug delivery
  publication-title: Biomater. Sci.
  doi: 10.1039/D0BM01164A
– volume: 3
  start-page: 77
  year: 2013
  ident: ref_38
  article-title: Arterial embolism
  publication-title: Int. J. Crit. Illn. Inj. Sci.
  doi: 10.4103/2229-5151.109429
– volume: 27
  start-page: 599
  year: 2020
  ident: ref_63
  article-title: In vitro and in vivo evaluation of liposomes modified with polypeptides and red cell membrane as a novel drug delivery system for myocardium targeting
  publication-title: Drug Deliv.
  doi: 10.1080/10717544.2020.1754525
– volume: 346
  start-page: 1234
  year: 2014
  ident: ref_101
  article-title: Neutrophils scan for activated platelets to initiate inflammation
  publication-title: Science
  doi: 10.1126/science.1256478
– volume: 13
  start-page: 1182
  year: 2018
  ident: ref_112
  article-title: Neutrophil membrane-coated nanoparticles inhibit synovial inflammation and alleviate joint damage in inflammatory arthritis
  publication-title: Nat. Nanotechnol.
  doi: 10.1038/s41565-018-0254-4
– volume: 8
  start-page: 933
  year: 2013
  ident: ref_93
  article-title: Nanoparticle-detained toxins for safe and effective vaccination
  publication-title: Nat. Nanotechnol.
  doi: 10.1038/nnano.2013.254
– volume: 8
  start-page: 336
  year: 2013
  ident: ref_92
  article-title: A biomimetic nanosponge that absorbs pore-forming toxins
  publication-title: Nat. Nanotechnol.
  doi: 10.1038/nnano.2013.54
– volume: 5
  start-page: eaaw6870
  year: 2019
  ident: ref_127
  article-title: Red blood cell–derived nanoerythrosome for antigen delivery with enhanced cancer immunotherapy
  publication-title: Sci. Adv.
  doi: 10.1126/sciadv.aaw6870
– volume: 13
  start-page: 709
  year: 2013
  ident: ref_31
  article-title: Macrophages in atherosclerosis: A dynamic balance
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/nri3520
– volume: 9
  start-page: 1560
  year: 2020
  ident: ref_120
  article-title: Biomimetic nanoparticles camouflaged in cancer cell membranes and their applications in cancer theranostics
  publication-title: Front. Oncol.
  doi: 10.3389/fonc.2019.01560
– volume: 69
  start-page: 407
  year: 2014
  ident: ref_26
  article-title: Cardiovascular disease prevention
  publication-title: Acta Clin. Belg.
  doi: 10.1179/2295333714Y.0000000069
– volume: 9
  start-page: 14475
  year: 2019
  ident: ref_66
  article-title: Cancer cell membrane-coated mesoporous silica loaded with superparamagnetic ferroferric oxide and paclitaxel for the combination of chemo/magnetocaloric therapy on MDA-MB-231 cells
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-019-51029-8
– volume: 23
  start-page: 225
  year: 2009
  ident: ref_33
  article-title: Basic mechanisms and pathogenesis of venous thrombosis
  publication-title: Blood Rev.
  doi: 10.1016/j.blre.2009.07.002
SSID ssj0021415
Score 2.4700243
SecondaryResourceType review_article
Snippet Cardiovascular diseases (CVDs) are the leading cause of death worldwide, causing approximately 17.9 million deaths annually, an estimated 31% of all deaths,...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 3428
SubjectTerms Anticoagulants
Atherosclerosis
Biomimetic Materials - chemical synthesis
Biomimetic Materials - chemistry
Biomimetic Materials - therapeutic use
Blood clots
Cardiovascular disease
Cardiovascular Diseases - drug therapy
Cell Membrane - chemistry
cell membrane coated nanoparticle
diagnosis and therapy
Drug Delivery Systems
Embolisms
Heart attacks
Humans
Hypertension
Inflammation
Intermittent claudication
Ischemia
Lipoproteins
Magnetic resonance imaging
Medical imaging
Nanomaterials
Nanoparticles
Neutrophils
Prevention
Proteins
Review
Stroke
Thrombosis
SummonAdditionalLinks – databaseName: Health & Medical Collection (ProQuest)
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3PT90wDLYYO2wXxH5SYFMm7TSpom2S9uWEoBpCk-AE0tMuVdI6DOnRAn38_9ht-uBtE9cmkdLYjj_H1meA72QxBNNJea2zGCuVYOwIJsTOGy0xc7Ns6Fpydp6fXqpfcz0PD259KKuc7sThom66mt_IDzKmUNWkj-bw9i7mrlGcXQ0tNF7Ba6Yu45KuYv4UcKXkncZMpqTQ_uBmbDiLPUUNqVTcgP2ZLxoo-_-HM_8ul3zmf062YSsAR3E0SvodbGD7Ht6UU7-2D_CbECAtFUdjVr8XnRclLhbiDG8oJG5RlB0By0bQhUqRciiIE9etuBiAY3slyrXiVDExc_Yf4fLk50V5GofOCXGtjFzG3kirE1QaE3SGGV3qQjvmwXHS-7SoPSY2rQkeWKUam-Z5QaaryRZRNlai_ASbbdfiDghtUM-Mb7zNkHyXczZtXEGYPFcus05FkExnWNWBVpy7WywqCi_42Kt_jj2CH6sltyOnxkuTj1kwq4lMhz186O6vqnBWFf2VyhutSEQUgaE1xubk_Dmt7CWFRBHsT2Ktgo321ZNGRfBtNUxC45QJSaV74DlqppiwiOZ8HrVgtRNmwpvRdRZBsaYfa1tdH2mv_wwM3gy7MqN3X97WHrzNuIKG33z0Pmwu7x_wC0Ggpfs66Pkj2_gKcQ
  priority: 102
  providerName: ProQuest
Title Recent Advances of Cell Membrane Coated Nanoparticles in Treating Cardiovascular Disorders
URI https://www.ncbi.nlm.nih.gov/pubmed/34198794
https://www.proquest.com/docview/2539957309
https://www.proquest.com/docview/2548415449
https://pubmed.ncbi.nlm.nih.gov/PMC8201295
https://doaj.org/article/b3f46d54dce548ea99a6eed0245f3675
Volume 26
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEB6a7SG5lLRNUyfpokJPBRPbkmzrmDXZhkJCKQksuRjJHrWBjbd0N_8_M34su2lpLr34YEkgj-bxjTV8A_CJLIZgOimvdRZDpSIMHcGE0HmjJSYuT9quJZdX6cWN-jrTs41WX1wT1tEDd4I7ddKrtNaqrpDANVpjbEp-nW8MvSS0y96XYt6QTPWpVkxxqbvDlJTUn953rWZxSflCLBW3Xt-IQi1Z_98Q5tNCyY3IM92HVz1kFGfdVl_DC2zewG4xdGp7C7eE_WipOOvu85di4UWB87m4xHtKhhsUxYIgZS3IlVKO3JfCibtGXLeQsfkhiq2yVDFwci4P4GZ6fl1chH3PhLBSRq5Cb6TVESqNETrDXC5Vph0z4JAgfZxVHiMbVwQMrFK1jdM0I6PVZIUoaytRvoNRs2jwPQhtUOfG194mSFHLORvXLiM0niqXWKcCiAYZllVPKM59LeYlJRYs9vIPsQfweb3kV8em8a_JEz6Y9UQmwm5fkHqUvazK59QjgJPhWMveOpdlwnS8mnybCeDjepgOjS9L6FQWDzxH5YqpimjOYacF650wB15OjiyAbEs_tra6PdLc_Wy5uxlwJUYf_Y9vO4a9hCts-J-QPoHR6vcDfiCItHJj2MlmGT3z6ZcxvJycX337Pm4t5BGuHhbZ
linkProvider Directory of Open Access Journals
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Nb9QwEB2VcigXxDdLCxgJLkhRk9hO4gNCJbBsabenrVRxCXYyKZW2SdtshfhT_EZm8rF0AfXW69pZeWeex2_i2TcAr2nHEE0n8Fpn0VPKR88RTfBcabTE0CVh27VkehBNDtWXI320Br-G_8JwWeUQE9tAXdQ5vyPfDllCVRMezfuzc4-7RvHt6tBCo4PFHv78QSlb8273I_n3TRiOP83Sidd3FfByZeTCK4202kel0UdnWO0kj7VjjRgnyzKI8xJ9G-R0dFqlChtEUUyw1oRTlIWVKOl7b8FtJaXhHZWMPy8TvIBOw-7mlAb97dOuwS02lKUEUnHD9ytnX9si4H-89u_yzCvn3fge3O2JqtjpkHUf1rB6ABvp0B_uIXwlxkmPip2uiqARdSlSnM_FFE8pBa9QpDUR2UJQAKfMvC_AEyeVmLVEtToW6UoxrBiUQJtHcHgjNn0M61Vd4VMQ2qBOTFmUNkQ6K52zQeFiygEi5ULr1Aj8wYZZ3suYczeNeUbpDJs9-8fsI3i7fOSs0_C4bvIHdsxyIstvtx_UF8dZb6uMfpWKCq3IRZTxoTXGRkQ2-Bq7lJSCjWBrcGvWx4Qm-4PgEbxaDpPT-IqGvFJf8hyVKBZIojlPOhQsV8LKewmFzxHEK_hYWerqSHXyvVUMZ5oXGv3s-mW9hI3JbLqf7e8e7G3CnZCrd_h9k96C9cXFJT4n-rVwL1rMC_h205vsN54FRt8
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Nb9QwEB2VIgGXis-SUsBIcEGKNontZH1AqKSsWkorDq204hLsZFIqbZPSbIX4a_w6ZvKx7QLqrdeNE3lnnsdv4skbgNe0YoimE3its-grFaDviCb4rjRaYuTGUdu1ZP8g3jlSn6Z6ugK_h29huKxyiIltoC7qnN-RjyKWUNWERzMq-7KIL9uT92c_fO4gxSetQzuNDiJ7-OsnpW_Nu91t8vWbKJp8PEx3_L7DgJ8rI-d-aaTVASqNATrDyid5oh3rxThZlmGSlxjYMKdt1CpV2DCOE4K4JsyiLKxESc-9BbcTqUNeY8n0MtkLaWfsTlGlNMHotGt2iw1lLKFU3Pz9yj7Ytgv4H8f9u1Tzyt43uQ9rPWkVWx3KHsAKVg_hbjr0insEX4l90q1iq6soaERdihRnM7GPp5SOVyjSmkhtISiYU5beF-OJk0octqS1OhbpUmGsGFRBm8dwdCM2fQKrVV3hUxDaoB6bsihthLRvOmfDwiWUD8TKRdYpD4LBhlneS5pzZ41ZRqkNmz37x-wevF3cctbpeVw3-AM7ZjGQpbjbH-rz46y3VUb_SsWFVuQiyv7QGmNjIh58pF1KSsc82BzcmvXxocku0ezBq8Vlchof15BX6gseo8aKxZJozHqHgsVMWIVvTKHUg2QJH0tTXb5SnXxv1cOZ8kVGb1w_rZdwh5ZX9nn3YO8Z3Iu4kIdfPelNWJ2fX-BzYmJz96KFvIBvN73G_gBrX0sM
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Recent+Advances+of+Cell+Membrane+Coated+Nanoparticles+in+Treating+Cardiovascular+Disorders&rft.jtitle=Molecules+%28Basel%2C+Switzerland%29&rft.au=Chaojie+Zhu&rft.au=Junkai+Ma&rft.au=Zhiheng+Ji&rft.au=Jie+Shen&rft.date=2021-06-05&rft.pub=MDPI+AG&rft.eissn=1420-3049&rft.volume=26&rft.issue=11&rft.spage=3428&rft_id=info:doi/10.3390%2Fmolecules26113428&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_b3f46d54dce548ea99a6eed0245f3675
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1420-3049&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1420-3049&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1420-3049&client=summon